Actively Recruiting
Aerobic Versus Resistive Intradialytic Training Effect on Atherogenic Index in Hemodialysis Patients
Led by Cairo University · Updated on 2025-07-09
60
Participants Needed
2
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating how aerobic and resistive exercises affect the atherogenic index in patients undergoing hemodialysis. This randomized controlled trial includes sixty men and women aged 40 to 60 years who receive maintenance hemodialysis three times a week. The study aims to compare the impact of different exercise types on cardiovascular risk factors in these patients. Participants are divided into three groups. The first group will perform moderate-intensity aerobic exercise using a cycle ergometer during the first half of their dialysis session, three times a week for 12 weeks. The second group will engage in moderate-intensity resistive training with ankle weights, also three times per week for 12 weeks. The third group will perform circulatory ankle pump exercises without additional resistance and will be evaluated at the start and end of the study. Throughout the study, patients will be monitored and evaluated for changes in their atherogenic index after three months. Assessments include exercise sessions integrated into their dialysis treatments, with warm-up and cool-down phases. The study follows ethical guidelines, and patients provide informed consent before participating. The total participation duration is 12 weeks with regular exercise sessions during dialysis.
CONDITIONS
Brief Title
Aerobic Versus Resistive Intradialytic Training Effect on Atherogeinc Index in Hemodialysis Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Maintenance hemodialysis for 3 months or more
- Body mass index (BMI) between 18.5 and 29.9 kg/m²
- Age between 40 and 60 years
- Receiving hemodialysis three times a week
You will not qualify if you...
- Central or peripheral nervous system diseases
- Serious complications such as heart failure, severe infection, or malignant tumor
- Uncontrolled hypertension with systolic blood pressure ≥ 200 mm Hg or diastolic blood pressure ≥ 120 mm Hg
- Unstable angina
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 weeks
Participants undergo one of three exercise training programs during their hemodialysis sessions: moderate intensity intradialytic aerobic training, moderate intensity intradialytic resistive training using ankle weights, or circulatory ankle pump exercises. These interventions are conducted three times per week during dialysis sessions.
3 sessions per week during dialysis
Trial Site Locations
Total: 2 locations
1
National Institute of Kidney and Urology, Mataria
Cairo, Select State, Egypt
Not Yet Recruiting
2
National Institute of Kidney and Urology, Mataria
Cairo, Egypt
Actively Recruiting
Research Team
M
mariam rezk rezk, lecturer assistant
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here